Annual revenue:
$41.95B+$1.84B(+4.59%)Summary
- As of today (April 15, 2025), ABT annual revenue is $41.95 billion, with the most recent change of +$1.84 billion (+4.59%) on December 31, 2024.
- During the last 3 years, ABT annual revenue has fallen by -$1.13 billion (-2.61%).
- ABT annual revenue is now -3.90% below its all-time high of $43.65 billion, reached on December 31, 2022.
Performance
ABT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$10.97B+$339.00M(+3.19%)Summary
- As of today (April 15, 2025), ABT quarterly revenue is $10.97 billion, with the most recent change of +$339.00 million (+3.19%) on December 31, 2024.
- Over the past year, ABT quarterly revenue has increased by +$733.00 million (+7.16%).
- ABT quarterly revenue is now -7.74% below its all-time high of $11.89 billion, reached on March 31, 2022.
Performance
ABT Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$41.95B+$733.00M(+1.78%)Summary
- As of today (April 15, 2025), ABT TTM revenue is $41.95 billion, with the most recent change of +$733.00 million (+1.78%) on December 31, 2024.
- Over the past year, ABT TTM revenue has increased by +$1.84 billion (+4.59%).
- ABT TTM revenue is now -7.90% below its all-time high of $45.55 billion, reached on June 30, 2022.
Performance
ABT TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.6% | +7.2% | +4.6% |
| 3 y3 years | -2.6% | +7.2% | +4.6% |
| 5 y5 years | +31.5% | +7.2% | +4.6% |
ABT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.9% | +4.6% | -7.7% | +12.6% | -7.9% | +5.0% |
| 5 y | 5-year | -3.9% | +31.5% | -7.7% | +49.8% | -7.9% | +33.4% |
| alltime | all time | -3.9% | +1251.5% | -7.7% | +255.3% | -7.9% | +5717.5% |
Abbott Laboratories Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $41.95B(+4.6%) | $10.97B(+3.2%) | $41.95B(+1.8%) |
| Sep 2024 | - | $10.63B(+2.5%) | $41.22B(+1.2%) |
| Jun 2024 | - | $10.38B(+4.1%) | $40.73B(+1.0%) |
| Mar 2024 | - | $9.96B(-2.7%) | $40.33B(+0.5%) |
| Dec 2023 | $40.11B(-8.1%) | $10.24B(+1.0%) | $40.11B(+0.4%) |
| Sep 2023 | - | $10.14B(+1.7%) | $39.96B(-0.7%) |
| Jun 2023 | - | $9.98B(+2.4%) | $40.23B(-3.1%) |
| Mar 2023 | - | $9.75B(-3.4%) | $41.51B(-4.9%) |
| Dec 2022 | $43.65B(+1.3%) | $10.09B(-3.1%) | $43.65B(-3.1%) |
| Sep 2022 | - | $10.41B(-7.5%) | $45.03B(-1.1%) |
| Jun 2022 | - | $11.26B(-5.4%) | $45.55B(+2.3%) |
| Mar 2022 | - | $11.89B(+3.7%) | $44.51B(+3.3%) |
| Dec 2021 | $43.08B(+24.5%) | $11.47B(+4.9%) | $43.08B(+1.8%) |
| Sep 2021 | - | $10.93B(+6.9%) | $42.31B(+5.2%) |
| Jun 2021 | - | $10.22B(-2.2%) | $40.23B(+7.8%) |
| Mar 2021 | - | $10.46B(-2.3%) | $37.34B(+7.9%) |
| Dec 2020 | $34.61B(+8.5%) | $10.70B(+20.9%) | $34.61B(+7.4%) |
| Sep 2020 | - | $8.85B(+20.8%) | $32.22B(+2.5%) |
| Jun 2020 | - | $7.33B(-5.2%) | $31.44B(-2.0%) |
| Mar 2020 | - | $7.73B(-7.1%) | $32.09B(+0.6%) |
| Dec 2019 | $31.90B(+4.3%) | $8.31B(+2.9%) | $31.90B(+1.8%) |
| Sep 2019 | - | $8.08B(+1.2%) | $31.36B(+1.4%) |
| Jun 2019 | - | $7.98B(+5.9%) | $30.93B(+0.7%) |
| Mar 2019 | - | $7.54B(-3.0%) | $30.72B(+0.5%) |
| Dec 2018 | $30.58B(+11.6%) | $7.76B(+1.4%) | $30.58B(+0.6%) |
| Sep 2018 | - | $7.66B(-1.4%) | $30.40B(+2.8%) |
| Jun 2018 | - | $7.77B(+5.1%) | $29.57B(+4.0%) |
| Mar 2018 | - | $7.39B(-2.6%) | $28.45B(+3.9%) |
| Dec 2017 | $27.39B(+31.3%) | $7.59B(+11.1%) | $27.39B(+9.0%) |
| Sep 2017 | - | $6.83B(+2.9%) | $25.13B(+6.5%) |
| Jun 2017 | - | $6.64B(+4.8%) | $23.61B(+5.8%) |
| Mar 2017 | - | $6.33B(+18.8%) | $22.30B(+7.0%) |
| Dec 2016 | $20.85B(+2.2%) | $5.33B(+0.6%) | $20.85B(+0.7%) |
| Sep 2016 | - | $5.30B(-0.6%) | $20.71B(+0.7%) |
| Jun 2016 | - | $5.33B(+9.2%) | $20.56B(+0.8%) |
| Mar 2016 | - | $4.88B(-5.8%) | $20.39B(-0.1%) |
| Dec 2015 | $20.41B(+0.8%) | $5.19B(+0.7%) | $20.41B(-0.8%) |
| Sep 2015 | - | $5.15B(-0.4%) | $20.57B(+0.3%) |
| Jun 2015 | - | $5.17B(+5.6%) | $20.50B(+0.6%) |
| Mar 2015 | - | $4.90B(-8.6%) | $20.39B(+0.7%) |
| Dec 2014 | $20.25B(+3.0%) | $5.36B(+5.5%) | $20.25B(+1.7%) |
| Sep 2014 | - | $5.08B(+0.4%) | $19.91B(+1.3%) |
| Jun 2014 | - | $5.06B(+6.4%) | $19.65B(-1.9%) |
| Mar 2014 | - | $4.75B(-5.2%) | $20.04B(-3.0%) |
| Dec 2013 | $19.66B(+3.2%) | $5.01B(+3.9%) | $20.66B(+9.7%) |
| Sep 2013 | - | $4.83B(-11.4%) | $18.84B(-2.3%) |
| Jun 2013 | - | $5.45B(+1.3%) | $19.28B(+0.7%) |
| Mar 2013 | - | $5.38B(+68.7%) | $19.14B(+0.5%) |
| Dec 2012 | $19.05B(-11.0%) | $3.19B(-39.4%) | $19.05B(+116.6%) |
| Sep 2012 | - | $5.26B(-0.9%) | $8.79B(-34.1%) |
| Jun 2012 | - | $5.31B(+0.6%) | $13.35B(-24.4%) |
| Mar 2012 | - | $5.28B(-174.8%) | $17.65B(-17.6%) |
| Dec 2011 | $21.41B(-39.1%) | -$7.07B(-172.0%) | $21.41B(-44.3%) |
| Sep 2011 | - | $9.82B(+2.1%) | $38.44B(+3.1%) |
| Jun 2011 | - | $9.62B(+6.4%) | $37.30B(+2.2%) |
| Mar 2011 | - | $9.04B(-9.3%) | $36.51B(+3.8%) |
| Dec 2010 | $35.17B(+14.3%) | $9.97B(+14.9%) | $35.17B(+3.5%) |
| Sep 2010 | - | $8.67B(-1.7%) | $33.99B(+2.8%) |
| Jun 2010 | - | $8.83B(+14.6%) | $33.08B(+4.2%) |
| Mar 2010 | - | $7.70B(-12.4%) | $31.74B(+3.2%) |
| Dec 2009 | $30.76B(+4.2%) | $8.79B(+13.3%) | $30.76B(+2.8%) |
| Sep 2009 | - | $7.76B(+3.6%) | $29.92B(+0.9%) |
| Jun 2009 | - | $7.49B(+11.6%) | $29.66B(+0.6%) |
| Mar 2009 | - | $6.72B(-15.5%) | $29.48B(-0.2%) |
| Dec 2008 | $29.53B(+13.9%) | $7.95B(+6.0%) | $29.53B(+2.5%) |
| Sep 2008 | - | $7.50B(+2.5%) | $28.80B(+4.1%) |
| Jun 2008 | - | $7.31B(+8.1%) | $27.68B(+3.5%) |
| Mar 2008 | - | $6.77B(-6.3%) | $26.73B(+3.2%) |
| Dec 2007 | $25.91B(+15.3%) | $7.22B(+13.2%) | $25.91B(+4.0%) |
| Sep 2007 | - | $6.38B(+0.1%) | $24.91B(+3.3%) |
| Jun 2007 | - | $6.37B(+7.1%) | $24.11B(+3.7%) |
| Mar 2007 | - | $5.95B(-4.4%) | $23.24B(+6.2%) |
| Dec 2006 | $22.48B(+0.6%) | $6.22B(+11.6%) | $21.87B(+0.8%) |
| Sep 2006 | - | $5.57B(+1.3%) | $21.70B(+0.9%) |
| Jun 2006 | - | $5.50B(+20.1%) | $21.51B(-0.1%) |
| Mar 2006 | - | $4.58B(-24.3%) | $21.54B(-3.6%) |
| Dec 2005 | $22.34B(+13.5%) | $6.05B(+12.3%) | $22.34B(+1.8%) |
| Sep 2005 | - | $5.38B(-2.5%) | $21.94B(+3.3%) |
| Jun 2005 | - | $5.52B(+2.6%) | $21.24B(+4.0%) |
| Mar 2005 | - | $5.38B(-4.8%) | $20.42B(+3.8%) |
| Dec 2004 | $19.68B | $5.65B(+20.8%) | $19.68B(+4.0%) |
| Sep 2004 | - | $4.68B(-0.5%) | $18.92B(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $4.70B(+1.3%) | $18.49B(+3.2%) |
| Mar 2004 | - | $4.64B(-5.2%) | $17.91B(+0.3%) |
| Dec 2003 | $17.28B(+13.1%) | $4.90B(+15.3%) | $17.85B(+16.0%) |
| Sep 2003 | - | $4.25B(+2.9%) | $15.39B(-0.6%) |
| Jun 2003 | - | $4.13B(-9.9%) | $15.48B(-1.2%) |
| Mar 2003 | - | $4.58B(+88.2%) | $15.67B(+2.6%) |
| Dec 2002 | $15.28B(-6.2%) | $2.43B(-43.9%) | $15.28B(-11.6%) |
| Sep 2002 | - | $4.34B(+0.6%) | $17.29B(+0.9%) |
| Jun 2002 | - | $4.31B(+3.0%) | $17.13B(+1.3%) |
| Mar 2002 | - | $4.19B(-5.8%) | $16.91B(+3.9%) |
| Dec 2001 | $16.29B(+18.5%) | $4.45B(+6.3%) | $16.29B(+4.8%) |
| Sep 2001 | - | $4.18B(+2.0%) | $15.54B(+5.9%) |
| Jun 2001 | - | $4.10B(+15.1%) | $14.68B(+5.2%) |
| Mar 2001 | - | $3.56B(-3.9%) | $13.95B(+1.5%) |
| Dec 2000 | $13.75B(+4.3%) | $3.70B(+11.7%) | $13.75B(+1.8%) |
| Sep 2000 | - | $3.32B(-1.6%) | $13.51B(+1.4%) |
| Jun 2000 | - | $3.37B(+0.5%) | $13.33B(+0.8%) |
| Mar 2000 | - | $3.35B(-3.3%) | $13.22B(+0.3%) |
| Dec 1999 | $13.18B(+5.3%) | $3.47B(+10.5%) | $13.18B(+0.8%) |
| Sep 1999 | - | $3.14B(-3.7%) | $13.07B(+0.8%) |
| Jun 1999 | - | $3.26B(-1.6%) | $12.97B(+1.5%) |
| Mar 1999 | - | $3.31B(-1.5%) | $12.78B(+2.1%) |
| Dec 1998 | $12.51B(+5.2%) | $3.37B(+10.9%) | $12.51B(+2.0%) |
| Sep 1998 | - | $3.04B(-1.0%) | $12.27B(+1.4%) |
| Jun 1998 | - | $3.07B(+0.7%) | $12.10B(+1.4%) |
| Mar 1998 | - | $3.04B(-2.5%) | $11.93B(+0.4%) |
| Dec 1997 | $11.89B(+8.0%) | $3.12B(+9.0%) | $11.89B(+1.1%) |
| Sep 1997 | - | $2.87B(-1.2%) | $11.76B(+1.9%) |
| Jun 1997 | - | $2.90B(-3.3%) | $11.54B(+1.8%) |
| Mar 1997 | - | $3.00B(+0.1%) | $11.34B(+3.0%) |
| Dec 1996 | $11.01B(+10.0%) | $3.00B(+13.2%) | $11.01B(+3.8%) |
| Sep 1996 | - | $2.65B(-2.0%) | $10.61B(+2.5%) |
| Jun 1996 | - | $2.70B(+1.0%) | $10.36B(+2.0%) |
| Mar 1996 | - | $2.67B(+2.9%) | $10.16B(+1.5%) |
| Dec 1995 | $10.01B(+9.4%) | $2.60B(+8.6%) | $10.01B(+1.2%) |
| Sep 1995 | - | $2.39B(-4.4%) | $9.90B(+1.4%) |
| Jun 1995 | - | $2.50B(-1.0%) | $9.76B(+3.1%) |
| Mar 1995 | - | $2.52B(+1.7%) | $9.47B(+3.4%) |
| Dec 1994 | $9.16B(+8.9%) | $2.48B(+10.1%) | $9.16B(+2.9%) |
| Sep 1994 | - | $2.25B(+2.3%) | $8.90B(+2.2%) |
| Jun 1994 | - | $2.20B(-0.5%) | $8.71B(+1.5%) |
| Mar 1994 | - | $2.22B(-0.6%) | $8.58B(+2.0%) |
| Dec 1993 | $8.41B(+7.1%) | $2.23B(+8.1%) | $8.41B(+1.6%) |
| Sep 1993 | - | $2.06B(-0.6%) | $8.28B(+1.1%) |
| Jun 1993 | - | $2.07B(+1.4%) | $8.18B(+2.1%) |
| Mar 1993 | - | $2.05B(-2.4%) | $8.02B(+2.1%) |
| Dec 1992 | $7.85B(+14.2%) | $2.10B(+6.5%) | $7.85B(+2.8%) |
| Sep 1992 | - | $1.97B(+3.1%) | $7.64B(+4.3%) |
| Jun 1992 | - | $1.91B(+1.6%) | $7.33B(+3.2%) |
| Mar 1992 | - | $1.88B(-0.4%) | $7.10B(+3.3%) |
| Dec 1991 | $6.88B(+11.7%) | $1.89B(+14.1%) | $6.88B(+2.6%) |
| Sep 1991 | - | $1.65B(-1.7%) | $6.70B(+2.2%) |
| Jun 1991 | - | $1.68B(+1.8%) | $6.55B(+2.8%) |
| Mar 1991 | - | $1.65B(-3.3%) | $6.37B(+3.5%) |
| Dec 1990 | $6.16B(+14.5%) | $1.71B(+13.5%) | $6.16B(+4.3%) |
| Sep 1990 | - | $1.51B(+0.2%) | $5.90B(+3.4%) |
| Jun 1990 | - | $1.50B(+4.5%) | $5.71B(+3.3%) |
| Mar 1990 | - | $1.44B(-1.2%) | $5.52B(+2.7%) |
| Dec 1989 | $5.38B(+9.0%) | $1.46B(+11.1%) | $5.38B(+2.9%) |
| Sep 1989 | - | $1.31B(-0.6%) | $5.23B(+1.9%) |
| Jun 1989 | - | $1.32B(+1.8%) | $5.13B(+1.8%) |
| Mar 1989 | - | $1.30B(-0.8%) | $5.04B(+2.2%) |
| Dec 1988 | $4.94B(+12.5%) | $1.31B(+7.7%) | $4.94B(+1.5%) |
| Sep 1988 | - | $1.21B(-1.4%) | $4.86B(+2.6%) |
| Jun 1988 | - | $1.23B(+3.5%) | $4.74B(+3.7%) |
| Mar 1988 | - | $1.19B(-3.7%) | $4.57B(+4.2%) |
| Dec 1987 | $4.39B(+15.2%) | $1.23B(+13.1%) | $4.39B(+4.0%) |
| Sep 1987 | - | $1.09B(+2.9%) | $4.22B(+3.7%) |
| Jun 1987 | - | $1.06B(+5.5%) | $4.07B(+3.1%) |
| Mar 1987 | - | $1.00B(-5.6%) | $3.95B(+3.6%) |
| Dec 1986 | $3.81B(+13.3%) | $1.06B(+13.0%) | $3.81B(+2.9%) |
| Sep 1986 | - | $940.90M(+0.3%) | $3.70B(+3.3%) |
| Jun 1986 | - | $938.00M(+8.4%) | $3.58B(+3.2%) |
| Mar 1986 | - | $865.50M(-9.3%) | $3.47B(+3.3%) |
| Dec 1985 | $3.36B(+8.3%) | $954.40M(+16.0%) | $3.36B(+3.2%) |
| Sep 1985 | - | $822.70M(-0.5%) | $3.26B(+2.9%) |
| Jun 1985 | - | $827.00M(+9.4%) | $3.16B(+0.8%) |
| Mar 1985 | - | $756.20M(-11.1%) | $3.14B(+1.1%) |
| Dec 1984 | $3.10B | $850.40M(+16.3%) | $3.10B(+37.7%) |
| Sep 1984 | - | $731.20M(-8.8%) | $2.25B(+48.0%) |
| Jun 1984 | - | $801.40M(+11.1%) | $1.52B(+111.1%) |
| Mar 1984 | - | $721.10M | $721.10M |
FAQ
- What is Abbott Laboratories annual revenue?
- What is the all time high annual revenue for Abbott Laboratories?
- What is Abbott Laboratories annual revenue year-on-year change?
- What is Abbott Laboratories quarterly revenue?
- What is the all time high quarterly revenue for Abbott Laboratories?
- What is Abbott Laboratories quarterly revenue year-on-year change?
- What is Abbott Laboratories TTM revenue?
- What is the all time high TTM revenue for Abbott Laboratories?
- What is Abbott Laboratories TTM revenue year-on-year change?
What is Abbott Laboratories annual revenue?
The current annual revenue of ABT is $41.95B
What is the all time high annual revenue for Abbott Laboratories?
Abbott Laboratories all-time high annual revenue is $43.65B
What is Abbott Laboratories annual revenue year-on-year change?
Over the past year, ABT annual revenue has changed by +$1.84B (+4.59%)
What is Abbott Laboratories quarterly revenue?
The current quarterly revenue of ABT is $10.97B
What is the all time high quarterly revenue for Abbott Laboratories?
Abbott Laboratories all-time high quarterly revenue is $11.89B
What is Abbott Laboratories quarterly revenue year-on-year change?
Over the past year, ABT quarterly revenue has changed by +$733.00M (+7.16%)
What is Abbott Laboratories TTM revenue?
The current TTM revenue of ABT is $41.95B
What is the all time high TTM revenue for Abbott Laboratories?
Abbott Laboratories all-time high TTM revenue is $45.55B
What is Abbott Laboratories TTM revenue year-on-year change?
Over the past year, ABT TTM revenue has changed by +$1.84B (+4.59%)